STAA Q2 2017 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$871M

Q2 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$22M+4.6% YoY

Gross Profit

$15M70.5% margin

Operating Income

-$1M-6.0% margin

Net Income

-$971,000-4.4% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

-$666,000

Free Cash Flow

-$1M

Stock-Based Comp.

$868,000

Balance Sheet

Total Assets

$64M

Total Liabilities

$25M

Stockholders' Equity

$38M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$21M	+4.6%
Gross Profit	$15M	$15M	+5.8%
Operating Income	-$1M	-$2M	+38.4%
Net Income	-$971,000	-$2M	+54.7%

Revenue Segments

Implantable Collamer Lenses

$16M74%

Intraocular Lenses

$4M20%

Other Surgical Products

$1M6%

Geographic Segments

Other Countries

$10M44%

CHINA

$6M27%

JAPAN

$4M20%

UNITED STATES

$2M10%